CD47-SIRPalpha Checkpoint Disruption in Metastases Requires Tumor-Targeting Antibody for Molecular and Engineered Macrophage Therapies.

Andrechak JC, Dooling LJ, Tobin MP, Zhang W, Hayes BH, Lee JY, Jin X, Irianto J, Discher DE
Cancers (Basel). 2022 Apr 11;14(8). pii: cancers14081930. doi: 10.3390/cancers14081930. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.